Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$230,352,496
+$3,780,802 QoQ
Shares Held
636,122
-1.2% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#79
of 3,131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rockefeller Capital Management L.P. holds $1,983,048,474 across 16 Drug Manufacturers - General names. AMGN ranks #5 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
559,339 | $670,888,028 | |
| 2 | JNJ |
Johnson & Johnson
|
1,137,643 | $288,927,190 | |
| 3 | ABBV |
AbbVie Inc.
|
980,805 | $246,809,766 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,848,360 | $237,514,257 | |
| 5 | AMGN |
Amgen Inc
This page
|
636,122 | $230,352,496 | |
| 6 | AZN |
Astrazeneca PLC
|
467,619 | $88,669,912 | |
| 7 | NVO |
Novo Nordisk A S
|
1,566,451 | $75,095,658 | |
| 8 | PFE |
Pfizer Inc
|
1,993,256 | $47,997,600 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $230,352,496 | 636,122 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $226,571,694 | 643,944 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $210,185,715 | 642,161 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $142,111,404 | 503,584 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $146,005,888 | 522,925 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $155,049,398 | 497,671 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $117,771,745 | 451,856 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $145,829,022 | 452,590 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $139,880,426 | 447,689 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $123,102,312 | 432,971 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $177,570,089 | 616,520 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $135,763,306 | 505,147 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $59,443,411 | 267,739 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $63,122,132 | 261,105 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $72,555,612 | 276,255 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $63,974,154 | 283,825 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $50,068,706 | 205,790 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $47,248,725 | 195,388 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $39,794,492 | 176,888 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $33,212,526 | 156,184 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $34,098,917 | 139,893 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $30,951,216 | 124,397 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $25,795,413 | 112,193 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $21,923,332 | 86,258 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $17,929,605 | 76,018 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $14,670,352 | 72,364 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||